newsfilter
← Latest News
PR Newswire·

Azenta Announces the Election of Dipal Doshi to its Board of Directors

Azenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader...